AGC Biologics Joins OTXL Clinical Development Network for Rare Disease Therapies

AGC Biologics has joined the Clinical Development Network of Orphan Therapeutics Accelerator (OTXL) as a manufacturing partner to support the development and commercialisation of therapies… The post AGC Biologics Joins OTXL Clinical Development Network for Rare Disease Therapies appeared first on PharmaSource .